Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mereo BioPharma (MREO) Interest Expenses (2023 - 2025)

Mereo BioPharma (MREO) has disclosed Interest Expenses for 3 consecutive years, with $23000.0 as the latest value for Q4 2025.

  • Quarterly Interest Expenses fell 93.87% to $23000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $255000.0 through Dec 2025, down 81.37% year-over-year, with the annual reading at $255000.0 for FY2025, 81.39% down from the prior year.
  • Interest Expenses for Q4 2025 was $23000.0 at Mereo BioPharma, down from $28000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $1.0 million in Q2 2023, with the low at $23000.0 in Q4 2025.
  • Average Interest Expenses over 3 years is $375500.0, with a median of $342000.0 recorded in 2023.
  • The sharpest move saw Interest Expenses increased 6.23% in 2024, then plummeted 93.87% in 2025.
  • Over 3 years, Interest Expenses stood at $353000.0 in 2023, then increased by 6.23% to $375000.0 in 2024, then tumbled by 93.87% to $23000.0 in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $23000.0, $28000.0, and $24000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.